| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/20/2008 | US7374888 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374769 Method for treating a trigeminal neuralgia by peripheral administration of a neurotoxin |
| 05/20/2008 | US7374768 Viral vaccines |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | US7374766 Immunogenic mixture of Hepatitis B surface antigens and Human papilloma-virus; minimizes number of compounds in formulation and generates strong systemic response; vaccines |
| 05/20/2008 | US7374765 Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| 05/20/2008 | US7374764 CD33-like protein |
| 05/20/2008 | US7374763 Foot-and-Mouth Disease virus (FMDV), or their epitopes; vaccine from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops, FMDV peptide epitopes are cloned by polymerace chain reaction PCR from VP1 gene of FMDV |
| 05/20/2008 | US7374762 Monoclonal antibody chemically coupled to maytansinoid, buffer, surfactant, tonicifying amount of sodium chloride, and water; freeze drying |
| 05/20/2008 | US7374761 Antigen-binding fragment (immunoglobulin) which bind to epitope of tumor necrosis factor (TNF) and inhibits its activity; diagnosis and treatment |
| 05/20/2008 | US7374760 Methods and compositions for nerve regeneration |
| 05/20/2008 | US7374756 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis |
| 05/20/2008 | US7374755 Therapeutic use of anti-TF-Antigen antibody |
| 05/20/2008 | US7374751 QS-21 and IL-12 as an adjuvant combination |
| 05/20/2008 | CA2569080A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/20/2008 | CA2469833C Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 05/20/2008 | CA2363947C Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2177695C Method of transmitting a biologically active material to a cell |
| 05/20/2008 | CA2172630C Cellular and serum protein anchors and conjugates |
| 05/15/2008 | WO2008058127A2 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | WO2008058081A1 Feline vaccines against avian influenza |
| 05/15/2008 | WO2008058035A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 05/15/2008 | WO2008057696A2 Compositions of pattern recognition receptor-ligand: lipid complexes and methods of use thereof |
| 05/15/2008 | WO2008057634A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 05/15/2008 | WO2008057562A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/15/2008 | WO2008057529A2 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp) |
| 05/15/2008 | WO2008057459A2 Antagonists of pcsk9 |
| 05/15/2008 | WO2008057458A2 Antagonists of pcsk9 |
| 05/15/2008 | WO2008057457A2 Antagonists of pcsk9 |
| 05/15/2008 | WO2008057396A2 Canine lyme disease vaccine |
| 05/15/2008 | WO2008057329A2 Method for detecting and controlling cancer |
| 05/15/2008 | WO2008057235A2 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 05/15/2008 | WO2008057158A2 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056705A1 M cell-specific antibody |
| 05/15/2008 | WO2008056263A2 Quality control methods for oil-in-water emulsions containing squalene |
| 05/15/2008 | WO2008056179A1 Novel compositions and uses thereof |
| 05/15/2008 | WO2008056174A2 Novel compositions and uses thereof |
| 05/15/2008 | WO2008055702A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/15/2008 | WO2008055354A1 Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods |
| 05/15/2008 | WO2008032324A3 Combination therapy for tumoral disease treatment |
| 05/15/2008 | WO2008028192A3 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/15/2008 | WO2007136893A3 Anti-fgf19 antibodies and methods using same |
| 05/15/2008 | WO2007135542A3 Progastrin inhibitors in the treatment of colon cancer |
| 05/15/2008 | WO2007127936A3 Methods and compositions for antibody therapy |
| 05/15/2008 | WO2007124082A3 Buffering agents for biopharmaceutical formulations |
| 05/15/2008 | WO2007112054A3 Facilitation of translocation of molecules through the gastrointestinal tract |
| 05/15/2008 | WO2007084765A3 Injectable combination therapy for eye disorders |
| 05/15/2008 | WO2007050866A8 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 05/15/2008 | US20080114156 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 05/15/2008 | US20080114070 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080112983 Barn Dust Extract Providing Protection From Allergies |
| 05/15/2008 | US20080112982 An genetically engineered bacterial flagella that is greater in length than flagella from a naturally occurring organism; comprises a mutation in FlgG protein, a binder of the nanotubes and a reporter molecule; drug delivery; medical equipment; miniaturization of electrical devices; fabric insulators |
| 05/15/2008 | US20080112981 Treatment of fine wrinkles with Clostridia Neurotoxins |
| 05/15/2008 | US20080112980 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 05/15/2008 | US20080112979 Oral Killed Vaccines and Method for Providing Same |
| 05/15/2008 | US20080112978 Method For Treatment of Hiv Infection |
| 05/15/2008 | US20080112977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof |
| 05/15/2008 | US20080112976 Directional induction of immune response by co-administration of antigens with chemokines |
| 05/15/2008 | US20080112975 Inducing adaptive immune response against a tumor or a pathogen via tissue destruction, followed by engraftment of allogenic cell adjuvants to region of tissue destruction; antitumor agents |
| 05/15/2008 | US20080112974 sublingual immunization offers a viable alternative to nasal and oral immunization in vaccines for respiratory diseases or sexually transmitted diseases; response in the respiratory, digestive or urogenital tracts of a mammal to a microbial pathogen; systemic cellular immune responses |
| 05/15/2008 | US20080112973 Chimeric papillomavirus-like particles |
| 05/15/2008 | US20080112972 Preservation of bioactive materials by freeze dried foam |
| 05/15/2008 | US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses; |
| 05/15/2008 | US20080112970 A suspension of killed bacteria, e.g., Leptospira, having a lipase activity of <50% than the lipase activity before heat treatment; vaccine using live or killed viruses in a stabilizing emulsion of lecithin, Quil A and cholesterol; bovine rhinotracheitis, parainfluenza, and respiratory synctial viruses |
| 05/15/2008 | US20080112969 Comprising a US2 gene having inserted a foreign DNA sequence capable of being expressed in a host cell that has been infected by the recombinant avian herpes virus; bird vaccines for Marek's disease, Newcastle disease and the infectious laryngotracheitis virus; veterinary medicine; genetic vectors |
| 05/15/2008 | US20080112965 Chlamydia OMP antigen |
| 05/15/2008 | US20080112964 Mutant Pneumolysin Proteins |
| 05/15/2008 | US20080112963 Inducing adaptive immune response against a tumor or a pathogen via tissue destruction, followed by engraftment of allogenic cell adjuvants to region of tissue destruction; antitumor agents |
| 05/15/2008 | US20080112962 Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies |
| 05/15/2008 | US20080112961 Using antibodies to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 05/15/2008 | US20080112960 Using epidermal growth factor receptor as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/15/2008 | US20080112959 Smallpox monoclonal antibody |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112957 Composition comprising immunoglobulin specific to epidermal growth factor receptor for treatment of cell proliferative disorders |
| 05/15/2008 | US20080112956 Using membrane proteins concentration as cancer indicator |
| 05/15/2008 | US20080112955 Method and composition for preventing pain in sickle cell patients |
| 05/15/2008 | US20080112954 Method for treating chronic pain |
| 05/15/2008 | US20080112953 Mixture comprising glutamic acid buffer and epidermal growth factor receptor specific immunoglobulin for use as therapeutic in treatment of metabolic disorders |
| 05/15/2008 | US20080112952 Using endothelial growth factor specific immunogllobulin to treat radiation-induced retinopathy |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112950 Naturally occurring IgM antibodies that bind lymphocytes |
| 05/15/2008 | US20080112949 Optimized dosing with anti-CD4 antibodies for tolerance induction in primates |
| 05/15/2008 | US20080112948 Water-soluble globulin concentrate for improving growth in animals |
| 05/15/2008 | US20080112947 I kappa b kinase complex as a target for the treatment of huntington's disease |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | US20080112940 Using expression vector comprising nucleotide sequences coding intracellular domain of calcium transport protein as therapeutic in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 05/15/2008 | US20080112925 Qs-21 and il-12 as an adjuvant combination |
| 05/15/2008 | US20080112924 Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |